Białostockie Centrum Onkologii

Name

Białostockie Centrum Onkologii

Legal name

Białostockie Centrum Onkologii im. Marii Skłodowskiej-Curie w Białymstoku

Website

https://onkologia.bialystok.pl

Company type

Private

Founded year

1956

Operating status

Operating

Headcount range

51–100 employees

Ownership category

akta.pro rank

Product category

Oncology Hospital Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (62231)

SIC

Services-Hospitals (8060)

akta.pro industry

PRIMARYHLAFAHAC

Oncology & Cancer Specialty Hospitals

Healthcare & Life Sciences/Healthcare Providers & Systems/Specialty Hospitals & Inpatient Specialty Care

SECONDARYHLAKAFAG

Surgical Oncology

Healthcare & Life Sciences/Specialist Medical Practice/Hematology & Oncology

SECONDARYHLAKAFAB

Medical Oncology

Healthcare & Life Sciences/Specialist Medical Practice/Hematology & Oncology

SECONDARYHLAKAJAD

Gynecologic Oncology

Healthcare & Life Sciences/Specialist Medical Practice/Obstetrics & Gynecology (OB/GYN)

SECONDARYHLAKAFAK

Gastrointestinal Oncology

Healthcare & Life Sciences/Specialist Medical Practice/Hematology & Oncology

Keywords

• Oncology hospital services
• Cancer treatment
• Cancer screening programs
• Robotic surgery
• Radiotherapy services

Headquarters

HQ city

Białystok

HQ country

Poland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. NFZ Public Healthcare Contracts: The hospital operates under contracts with Narodowy Fundusz Zdrowia (NFZ) - the Polish national health fund. All medical services are reimbursed according to publicly funded healthcare tariffs. The hospital has contracts exceeding 400 million PLN annually.
2. Government Budget Funding (Narodowa Strategia Onkologiczna): Funding from the state budget for oncology strategy initiatives including equipment purchases for genetics and rehabilitation - e.g., 1,026,328.50 PLN for genetic diagnostics equipment and 1,565,119.19 PLN for rehabilitation equipment.
3. European Union Project Funding: European Union funding through Krajowy Plan Odbudowy (KPO), Interreg programs, and other EU initiatives supporting infrastructure development, digital transformation, and prevention programs.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels10 records

Core offering

Białostockie Centrum Onkologii is a public multi-specialist oncology hospital providing comprehensive cancer diagnosis and treatment across six organ-specific Cancer Units (breast, colorectal, prostate, skin/melanoma, gynecological, various cancers). It offers surgical oncology including robotic-assisted surgery, chemotherapy, radiotherapy, diagnostic imaging, rehabilitation, psychological support, palliative care, and population-based cancer screening, all reimbursed through the Polish National Health Fund (NFZ). The hospital also operates the Podlaskie Cancer Registry and participates in the National Oncology Network as a SOLO III center.

Product overview

Białostockie Centrum Onkologii (BCO) is a multi-specialist oncology hospital providing comprehensive cancer care services. The facility operates as a single unified hospital with multiple specialized units: six organ-specific Cancer Units (Breast Cancer Unit, Colorectal Cancer Unit, Prostate Cancer Unit, Skin Cancer Melanoma Unit, Gynecological Cancer Unit, and Various Cancers Diagnosis Unit), diagnostic departments (Imaging, CT/MRI, Laboratory, Pathomorphology, Nuclear Medicine, Medical Physics), treatment wards (Radiotherapy, Clinical Oncology with chemotherapy, Surgery, Anesthesiology/ICU), and support services (Rehabilitation, Psychology, Endoscopy). BCO also manages the Podlaskie Cancer Registry and implements various EU-funded prevention programs. The hospital utilizes advanced technologies including robotic surgery and participates in the National Oncology Network (KSO) as a SOLO III specialized center.

Differentiator

Problem solved

Functional benefit

Brands

• Breast Cancer Unit (BCU): Specialized unit for breast cancer diagnosis and treatment.
• Colorectal Cancer Unit (CCU)
• Skin Cancer Melanoma Unit (SCMU)
• Prostate Cancer Unit (PCU)
• Gynecological Cancer Unit (GCU)
• Various Cancers Diagnosis Unit (VCDU)
• Podlaskie Biuro Rejestracji Nowotworów

Products and services

• Breast Cancer Unit (BCU) Specialized multidisciplinary unit for breast cancer diagnosis, surgical treatment, breast reconstruction, chemotherapy, radiotherapy, and follow-up care; serves as a core unit of the National Oncology Network.
• Colorectal Cancer Unit (CCU) Specialized unit for surgical and oncological treatment of colorectal cancer, including gastrointestinal cancer surgery and perioperative care.
• Prostate Cancer Unit (PCU) Specialized urological oncology unit for prostate cancer screening, diagnosis, robotic-assisted surgery, and post-treatment urinary function management.
• Skin Cancer Melanoma Unit (SCMU) Specialized unit for diagnosis, dermatological monitoring, and surgical treatment of skin cancers and melanoma.
• Gynecological Cancer Unit (GCU) Specialized surgical unit for gynecological cancer treatment including fertility preservation considerations and comprehensive perioperative care.
• Various Cancers Diagnosis Unit (VCDU) Coordination unit for diagnosis and treatment planning of cancer types not covered by the dedicated organ-specific units, including multidisciplinary consilia.
• Robotic Surgery Program (Da Vinci) Robotic-assisted oncological surgery using the Da Vinci system for radical cystectomy, liver resection, gynecological, colorectal, and prostate procedures; 500+ robotic procedures performed.
• Radiotherapy Services Radiation therapy treatment delivered through the Radiotherapy Department and inpatient Radiotherapy Ward I, supported by the Medical Physics Department.
• Clinical Oncology and Chemotherapy Clinical oncology ward (Oddział Onkologii Klinicznej im. dr E. Pileckiej) with day chemotherapy sub-unit providing systemic anticancer drug therapy.
• CT and MRI Diagnostics Computed tomography (CT) and magnetic resonance imaging (MRI) diagnostic services for oncology patients.
• Nuclear Medicine Diagnostics Nuclear medicine diagnostics and treatments including PET scans and radioisotope therapy.
• Laboratory Diagnostics Clinical laboratory testing and diagnostics including genetic diagnostics capabilities funded under Narodowa Strategia Onkologiczna.
• Pathomorphology Diagnostics Histopathological and morphological diagnostics supporting cancer diagnosis and treatment planning.
• Endoscopy Services Endoscopic diagnostic and therapeutic procedures supporting gastrointestinal and colorectal cancer pathways.
• Oncological Rehabilitation Oncological rehabilitation services for cancer patients during and after treatment, including equipment funded under Narodowa Strategia Onkologiczna (1.57M PLN).
• Pain Management Unit Specialized clinical unit for cancer-related pain treatment and palliative pain management.
• Psychological Counseling Psychological support and counseling services for cancer patients and their families throughout treatment.
• DiLO Fast Oncology Therapy (Szybka Terapia Onkologiczna)

Quantifiable outcome

• 213,521 consultations provided in 2025
• +3 more outcomes

Named customers3 records

Segments7 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Five partnerships are on record, tiered core, major and minor.

• Krajowa Sieć Onkologiczna (National Oncology Network)coreStrategic or Co-development Partner · 1 December 2019BCO participates in the National Oncology Network as SOLO III (Specjalistyczny Ośrodek Leczenia Onkologicznego - Specialized Oncology Treatment Center). The hospital served in the pilot program from December 1, 2019 to March 30, 2023, and continues as a member after the law was signed on March 30, 2023. The network ensures equal access to coordinated and comprehensive oncology care regardless of residence.
• Podlaskie Voivodeship GovernmentmajorStrategic or Co-development PartnerRegional government support for oncology services, including hosting the Medical Fund ranking announcement conference and ongoing collaboration on healthcare development.
• Jagiellonia BiałystokminorGTM or Marketing PartnerSports club partnership providing match vouchers to men participating in the Men's November prostate cancer screening campaign as incentive for health checks.
• Centrum Treningowe N50minorGTM or Marketing PartnerTraining center partnership providing vouchers to men participating in Men's November prostate cancer screening, promoting physical activity as part of cancer prevention.
• Barberia For MenminorGTM or Marketing PartnerBarbershop partnership for Men's November 2025 campaign inauguration, hosting the event launch and promoting prostate cancer awareness among men.

Scale indicators15 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Zachodniopomorskie Centrum Onkologii (West Pomeranian Oncology Center): Regional oncology hospital in Szczecin delivering surgical, systemic, and radiation oncology across organ-specific units under the Polish public healthcare system. Directly comparable as another voivodeship-level NFZ-contracted specialty facility.
• Maria Skłodowska-Curie National Research Institute of Oncology (NIO-PIB): Poland's flagship national oncology research institute and multi-site specialty cancer hospital (Warsaw, Gliwice, Kraków). Directly comparable as a multi-specialist public oncology center with research, surgical, and radiotherapy capabilities serving as a hub in the National Oncology Network.
• Wielkopolskie Centrum Onkologii (Greater Poland Cancer Center): Regional multi-specialist oncology hospital in Poznań serving the Wielkopolskie voivodeship under the same NFZ reimbursement model and KSO network structure. Closely comparable in scope, patient volume, and public hospital mandate.
• Świętokrzyskie Centrum Onkologii (Holy Cross Cancer Center): Regional oncology center in Kielce providing multi-organ cancer diagnostics, surgery, radiotherapy, and chemotherapy under the same NFZ/KSO framework. Directly comparable public specialty hospital at the voivodeship level.
• Kujawsko-Pomorskie Centrum Onkologii (Kuyavian-Pomeranian Oncology Center): Voivodeship-level public oncology hospital in Bydgoszcz offering comparable multi-organ cancer units, surgery, and radiotherapy under the same NFZ reimbursement and KSO network design.
• Dolnośląskie Centrum Onkologii (Lower Silesian Oncology Center): Regional oncology specialty hospital in Wrocław operating as a SOLO center within the National Oncology Network. Directly comparable as a Polish public voivodeship-level multi-organ cancer treatment provider.
• Centrum Onkologii Ziemi Lubelskiej (Lublin Oncology Center): Public multi-organ oncology hospital in Lublin operating under the same NFZ contracts, KSO framework, and Polish oncology strategy funding streams. Directly comparable as a neighboring voivodeship specialty oncology provider.

Broad incumbents

• European Institute of Oncology (IEO): Large private-nonprofit specialty oncology hospital and research center in Milan. Comparable as a multi-organ cancer treatment facility with surgical oncology and research capabilities, but operates on a different funding model (private + SSN reimbursement) and at a substantially larger scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCdDbnxhXmbT-dfUUZDF2LMw
• Facebookpl-pl.facebook.com/pages/category/Hospital/Bia%C5%82ostockie-Centrum-Onkologii-im-Marii-Sk%C5%82odowskiej-Curie-117196695649276
• Instagraminstagram.com/bialostockiecentrumonkologii
• LinkedInlinkedin.com/company/bia%C5%82ostockie-centrum-onkologii

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Białostockie Centrum Onkologii